Seattle Genetics - Stock Price History | SGEN

Historical daily share price chart and data for Seattle Genetics since 2020 adjusted for splits. The latest closing stock price for Seattle Genetics as of July 13, 2020 is 168.58.
  • The all-time high Seattle Genetics stock closing price was 181.17 on July 09, 2020.
  • The Seattle Genetics 52-week high stock price is 182.97, which is 8.5% above the current share price.
  • The Seattle Genetics 52-week low stock price is 65.44, which is 61.2% below the current share price.
  • The average Seattle Genetics stock price for the last 52 weeks is 113.56.
Seattle Genetics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 80.2825 57.4900 121.6200 56.3700 114.2600 101.66%
2018 62.0857 56.1300 82.7600 48.1300 56.6600 5.91%
2017 58.8818 53.0000 68.9100 45.9200 53.5000 1.38%
2016 44.8635 41.9200 73.7100 26.8700 52.7700 17.58%
2015 40.5791 32.5400 51.6100 30.5400 44.8800 39.68%
2014 39.8702 40.1800 55.1400 31.1000 32.1300 -19.45%
2013 36.8935 24.1400 48.4800 24.1400 39.8900 72.16%
2012 22.7221 16.4000 29.6750 16.4000 23.1700 38.62%
2011 17.2663 15.5900 22.2800 12.6700 16.7150 11.81%
2010 12.8036 10.5400 17.3500 9.3400 14.9500 47.15%
2009 10.0188 9.1200 14.8000 7.2300 10.1600 13.65%
2008 9.7185 11.3000 12.9700 7.4500 8.9400 -21.58%
2007 9.8390 5.2800 13.1300 5.2800 11.4000 113.88%
2006 4.8641 4.7400 6.2200 3.8200 5.3300 12.92%
2005 5.2173 6.0500 6.4000 3.6400 4.7200 -27.72%
2004 7.4505 9.1000 10.7500 4.7600 6.5300 -23.89%
2003 4.6588 3.2700 8.8500 2.2500 8.5800 176.77%
2002 4.2766 5.6900 6.9100 2.6400 3.1000 -45.61%
2001 6.0685 8.5000 10.3800 3.6500 5.7000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $29.182B $0.917B
Seattle Genetics is a biotechnology company focused on the development and commercialization of innovative antibody-based therapies for the treatment of cancer. Seattle Genetics is leading the field in developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of antibodies to deliver cell-killing agents directly to cancer cells. The company's lead product, ADCETRIS? (brentuximab vedotin) is an ADC that, in collaboration with Takeda Pharmaceutical Company Limited, is commercially available for two indications in more than 45 countries, including the U.S., Canada, Japan and members of the European Union. Additionally, ADCETRIS is being evaluated broadly in more than 30 ongoing clinical trials. Seattle Genetics is also advancing a robust pipeline of clinical-stage ADC programs, including SGN-CD19A, SGN-CD33A, SGN-LIV1A, SGN-CD70A, ASG-22ME and ASG-15ME.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $147.085B 16.19
Bristol Myers Squibb (BMY) United States $130.670B 10.92
Gilead Sciences (GILD) United States $96.185B 12.47
CSL (CSLLY) Australia $88.721B 0.00
Vertex Pharmaceuticals (VRTX) United States $73.847B 50.77
Regeneron Pharmaceuticals (REGN) United States $67.758B 26.12
Illumina (ILMN) United States $54.262B 55.76
Biogen (BIIB) United States $45.125B 7.72
Moderna (MRNA) United States $26.646B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $24.421B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.635B 10.15
Genmab (GMAB) Denmark $22.678B 18.68
BioMarin Pharmaceutical (BMRN) United States $22.496B 203.93
Incyte (INCY) United States $21.859B 0.00
Genmab (GNMSF) Denmark $21.347B 63.38
Alnylam Pharmaceuticals (ALNY) United States $17.620B 0.00
BioNTech SE (BNTX) Germany $17.599B 0.00
BeiGene (BGNE) Cayman Islands $16.634B 0.00
Exact Sciences (EXAS) United States $13.508B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
Sarepta Therapeutics (SRPT) United States $12.633B 0.00
Galapagos (GLPG) Belgium $12.465B 36.67
ARGENX SE-ADR (ARGX) Netherlands $11.791B 0.00
Horizon Therapeutics Public (HZNP) Ireland $10.655B 26.22
QIAGEN (QGEN) Netherlands $10.301B 29.95
Bio-Techne Corp (TECH) United States $10.058B 66.45
Immunomedics (IMMU) United States $9.229B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.155B 0.00
Guardant Health (GH) United States $7.597B 0.00
Exelixis (EXEL) United States $7.317B 25.66
SWEDISH ORP BIO (BIOVF) Sweden $6.750B 16.79
Ascendis Pharma (ASND) Denmark $6.444B 0.00
Repligen (RGEN) United States $6.408B 112.39
Novavax (NVAX) United States $6.046B 0.00
Vir Biotechnology (VIR) United States $5.921B 0.00
Adaptive Biotechnologies (ADPT) United States $5.606B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.343B 114.97
Acceleron Pharma (XLRN) United States $5.169B 0.00
Reata Pharmaceuticals (RETA) United States $5.086B 0.00
Mirati Therapeutics (MRTX) United States $4.943B 0.00
Zai Lab (ZLAB) China $4.941B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.889B 0.00
Emergent Biosolutions (EBS) United States $4.788B 31.39
Global Blood Therapeutics (GBT) United States $4.301B 0.00
MorphoSys AG (MOR) Germany $4.245B 32.93
MyoKardia (MYOK) United States $4.230B 0.00
China Biologic Products (CBPO) China $4.194B 23.32
Blueprint Medicines (BPMC) United States $4.154B 0.00
Inovio Pharmaceuticals (INO) United States $4.050B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.936B 0.00
Amicus Therapeutics (FOLD) United States $3.875B 0.00
NeoGenomics (NEO) United States $3.685B 269.11
Halozyme Therapeutics (HALO) United States $3.683B 0.00
Bluebird Bio (BLUE) United States $3.379B 0.00
Arena Pharmaceuticals (ARNA) United States $3.212B 0.00
Alkermes (ALKS) Ireland $3.021B 59.47
Deciphera Pharmaceuticals (DCPH) United States $2.918B 0.00
Insmed (INSM) United States $2.663B 0.00
Denali Therapeutics (DNLI) United States $2.621B 0.00
Fate Therapeutics (FATE) United States $2.580B 0.00
Amarin (AMRN) Ireland $2.552B 0.00
PHARMA MAR SA (PHMMF) Spain $2.388B 0.00
Twist Bioscience (TWST) United States $2.114B 0.00
Principia Biopharma (PRNB) United States $2.068B 0.00
Viela Bio (VIE) United States $1.956B 0.00
UniQure (QURE) Netherlands $1.953B 0.00
I-Mab (IMAB) China $1.901B 0.00
Ligand Pharmaceuticals (LGND) United States $1.823B 70.97
Eidos Therapeutics (EIDX) United States $1.800B 0.00
Alector (ALEC) United States $1.782B 0.00
Editas Medicine (EDIT) United States $1.739B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.713B 0.00
Sorrento Therapeutics (SRNE) United States $1.619B 0.00
Epizyme (EPZM) United States $1.513B 0.00
Intra-Cellular Therapies (ITCI) United States $1.508B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.503B 0.00
Adverum Biotechnologies (ADVM) United States $1.468B 0.00
Sangamo Therapeutics (SGMO) United States $1.445B 0.00
Cytokineticsorporated (CYTK) United States $1.428B 0.00
Zymeworks (ZYME) Canada $1.426B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.421B 0.00
Mersana Therapeutics (MRSN) United States $1.378B 0.00
Mesoblast (MESO) Australia $1.373B 0.00
Zealand Pharma (ZEAL) Denmark $1.370B 0.00
Zealand Pharma (ZLDPF) Denmark $1.369B 0.00
Revance Therapeutics (RVNC) United States $1.354B 0.00
REGENXBIO (RGNX) United States $1.353B 0.00
Arvinas (ARVN) United States $1.340B 0.00
NantKwest (NK) United States $1.301B 0.00
Beam Therapeutics (BEAM) United States $1.289B 0.00
Akcea Therapeutics (AKCA) United States $1.285B 0.00
Coherus BioSciences (CHRS) United States $1.259B 8.79
NGM Biopharmaceuticals (NGM) United States $1.231B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.163B 0.00
Intellia Therapeutics (NTLA) United States $1.102B 0.00
Arcus Biosciences (RCUS) United States $1.043B 0.00
Compugen (CGEN) Israel $1.024B 0.00
Alcobra (ARCT) United States $1.004B 0.00
Athenex (ATNX) United States $0.979B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.946B 0.00
VBI Vaccines (VBIV) United States $0.876B 0.00
Heska (HSKA) United States $0.870B 0.00
Retrophin (RTRX) United States $0.857B 0.00
Myriad Genetics (MYGN) United States $0.850B 43.85
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Cara Therapeutics (CARA) United States $0.820B 0.00
Pharming Group (PHGUF) Netherlands $0.817B 21.75
Dynavax Technologies (DVAX) United States $0.784B 0.00
Morphic Holding (MORF) United States $0.751B 0.00
Intrexon (PGEN) United States $0.749B 0.00
Vericel (VCEL) United States $0.731B 135.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.716B 0.00
Castle Biosciences (CSTL) United States $0.715B 0.00
Cellectis S.A (CLLS) France $0.702B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.699B 0.00
Codexis (CDXS) United States $0.676B 0.00
Kadmon Holdings (KDMN) United States $0.656B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Frequency Therapeutics (FREQ) United States $0.637B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.620B 5.31
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Agenus (AGEN) United States $0.593B 0.00
Cue Biopharma (CUE) United States $0.590B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.572B 0.00
Kala Pharmaceuticals (KALA) United States $0.556B 0.00
MiMedx (MDXG) United States $0.552B 0.00
AnaptysBio (ANAB) United States $0.550B 0.00
Syros Pharmaceuticals (SYRS) United States $0.523B 0.00
Athersys (ATHX) United States $0.522B 0.00
Cel-Sci (CVM) United States $0.522B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.521B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.519B 0.00
Anika Therapeutics (ANIK) United States $0.502B 16.15
Clovis Oncology (CLVS) United States $0.490B 0.00
UROGEN PHARMA (URGN) United States $0.487B 0.00
Prothena (PRTA) Ireland $0.465B 0.00
AC Immune SA (ACIU) Switzerland $0.463B 0.00
DBV Technologies S.A (DBVT) France $0.460B 0.00
Scholar Rock Holding (SRRK) United States $0.460B 0.00
MeiraGTx Holdings (MGTX) United States $0.433B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.425B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.425B 0.00
Protagonist Therapeutics (PTGX) United States $0.417B 0.00
BioDelivery Sciences (BDSI) United States $0.415B 21.82
Geron (GERN) United States $0.407B 0.00
CytomX Therapeutics (CTMX) United States $0.399B 0.00
Puma Biotechnology (PBYI) United States $0.399B 0.00
OSMOTICA PHARM (OSMT) United States $0.398B 0.00
Merus (MRUS) Netherlands $0.397B 0.00
Precision BioSciences (DTIL) United States $0.395B 0.00
Avid Bioservices (CDMO) United States $0.389B 0.00
Kamada (KMDA) Israel $0.378B 15.74
Aeglea BioTherapeutics (AGLE) United States $0.374B 0.00
MannKind (MNKD) United States $0.352B 0.00
Albireo Pharma (ALBO) United States $0.347B 0.00
WAVE Life Sciences (WVE) Singapore $0.345B 0.00
ANI Pharmaceuticals (ANIP) United States $0.344B 6.69
Affimed (AFMD) Germany $0.323B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.314B 0.00
ChromaDex (CDXC) United States $0.313B 0.00
PDL BioPharma (PDLI) United States $0.309B 271.00
Seres Therapeutics (MCRB) United States $0.304B 0.00
Cellular Biomedicine (CBMG) United States $0.299B 0.00
Starpharma Holdings (SPHRY) Australia $0.289B 0.00
Prometic Life Sciences (LMNL) Canada $0.277B 0.00
Pfenex (PFNX) United States $0.272B 0.00
Menlo Therapeutics (MNLO) United States $0.272B 0.00
Spero Therapeutics (SPRO) United States $0.263B 0.00
IBio (IBIO) United States $0.260B 0.00
Celldex Therapeutics (CLDX) United States $0.251B 0.00
Northwest Biotherapeutics (NWBO) United States $0.251B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.248B 0.00
Abeona Therapeutics (ABEO) United States $0.239B 0.00
ADMA Biologics Inc (ADMA) United States $0.238B 0.00
Dyadic (DYAI) United States $0.230B 0.00
IVERIC Bio (ISEE) United States $0.226B 0.00
NextCure (NXTC) United States $0.224B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.221B 0.00
Aduro Biotech (ADRO) United States $0.220B 0.00
Fortress Biotech (FBIO) United States $0.216B 0.00
Five Prime Therapeutics (FPRX) United States $0.216B 0.00
Verastem (VSTM) United States $0.215B 0.00
Pluristem Therapeutics (PSTI) Israel $0.214B 0.00
HOOKIPA Pharma (HOOK) United States $0.210B 0.00
Selecta Biosciences (SELB) United States $0.207B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.203B 3.06
GENFIT S.A (GNFT) France $0.202B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.201B 0.00
XOMA (XOMA) United States $0.200B 0.00
Sutro Biopharma (STRO) United States $0.197B 0.00
Liquidia Technologies (LQDA) United States $0.197B 0.00
Aptinyx (APTX) United States $0.196B 0.00
Exicure (XCUR) United States $0.196B 0.00
POXEL SA FRANCE (PXXLF) France $0.190B 0.00
Strongbridge Biopharma (SBBP) United States $0.180B 0.00
Trevena (TRVN) United States $0.170B 0.00
ARAVIVE, INC (ARAV) United States $0.170B 0.00
Theratechnologies (THTX) Canada $0.168B 0.00
Aytu Bioscience (AYTU) United States $0.159B 0.00
Bellus Health (BLU) Canada $0.156B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.154B 0.00
CorMedix Inc (CRMD) United States $0.154B 0.00
Kindred Biosciences (KIN) United States $0.151B 0.00
TELA Bio (TELA) United States $0.151B 0.00
Gritstone Oncology (GRTS) United States $0.150B 0.00
Cerecor (CERC) United States $0.147B 0.00
VTv Therapeutics (VTVT) United States $0.146B 0.00
Applied Genetic Technologies (AGTC) United States $0.145B 0.00
VolitionRX (VNRX) United States $0.144B 0.00
Cidara Therapeutics (CDTX) United States $0.144B 0.00
Celyad SA (CYAD) Belgium $0.137B 0.00
Biofrontera AG (BFRA) Germany $0.135B 0.00
Lumos Pharma (LUMO) United States $0.132B 0.00
Oncobiologics (OTLK) United States $0.129B 0.00
Cyclerion Therapeutics (CYCN) United States $0.129B 0.00
Enzo Biochem (ENZ) United States $0.126B 0.00
PHASEBIO PHARMA (PHAS) United States $0.125B 0.00
AquaBounty Technologies (AQB) United States $0.124B 0.00
Orgenesis (ORGS) United States $0.124B 0.00
Arbutus Biopharma (ABUS) United States $0.121B 0.00
Palatin Technologies (PTN) United States $0.114B 2.93
Lineage Cell Therapeutics (LCTX) United States $0.114B 0.00
Protalix BioTherapeutics (PLX) Israel $0.114B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.113B 0.00
AIT Therapeutics (XAIR) United States $0.105B 0.00
Eton Pharmaceuticals (ETON) United States $0.104B 0.00
Unum Therapeutics (UMRX) United States $0.102B 0.00
Windtree Therapeutics (WINT) United States $0.091B 0.00
Cardiff Oncology (CRDF) United States $0.090B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.089B 0.00
Checkpoint Therapeutics (CKPT) United States $0.089B 0.00
Cocrystal Pharma (COCP) United States $0.087B 0.00
Antibe Therapeutics (ATBPF) Canada $0.085B 0.00
DiaMedica Therapeutics (DMAC) United States $0.082B 0.00
Adocia (ADOCY) France $0.080B 0.00
Vaccinex (VCNX) United States $0.077B 0.00
Clearside Biomedical (CLSD) United States $0.077B 0.00
Organovo Holdings (ONVO) United States $0.076B 0.00
SESEN BIO, INC (SESN) United States $0.075B 0.00
Emmaus Life Sciences (EMMA) United States $0.073B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.071B 0.00
Catalyst Biosciences (CBIO) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.068B 0.00
Proteostasis Therapeutics (PTI) United States $0.067B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.067B 0.00
Happiness Biotech Group (HAPP) China $0.066B 0.00
Stealth BioTherapeutics (MITO) United States $0.065B 0.00
Synlogic (SYBX) United States $0.061B 0.00
Idera Pharmaceuticals (IDRA) United States $0.058B 0.00
AnPac Bio-Medical Science (ANPC) China $0.058B 0.00
Ecology Coatings (ABVC) United States $0.057B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.057B 0.00
CollPlant Holdings (CLGN) Israel $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.049B 0.00
Signal Genetics (MGEN) United States $0.046B 0.00
Apricus Biosciences (SEEL) United States $0.045B 0.00
Prima BioMed (IMMP) Australia $0.044B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
Curis (CRIS) United States $0.043B 0.00
Bionano Genomics (BNGO) United States $0.042B 0.00
Edesa Biotech (EDSA) Canada $0.041B 0.00
Celsion (CLSN) United States $0.041B 0.00
ATyr Pharma (LIFE) United States $0.036B 0.00
Pulmatrix (PULM) United States $0.035B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
Advaxis (ADXS) United States $0.033B 0.00
OvaScience (MLND) United States $0.031B 0.00
Chanticleer Holdings (SONN) United States $0.030B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.030B 0.00
Spherix (AIKI) United States $0.030B 0.00
Alimera Sciences (ALIM) United States $0.030B 0.00
Cesca Therapeutics (THMO) United States $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.027B 0.00
IMMURON (IMRN) Australia $0.026B 0.00
BioPharmX (TMBR) United States $0.026B 0.00
Evogene (EVGN) Israel $0.026B 0.00
Novogen (KZIA) Australia $0.025B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
Cleveland BioLabs (CBLI) United States $0.024B 0.00
FORTE BIOSCIENC (FBRX) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.021B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
Prana Biotechnology (ATHE) Australia $0.021B 0.00
Genetic Technologies (GENE) Australia $0.020B 0.00
BioCardia (BCDA) United States $0.017B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Neuralstem (SNCA) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
AEterna Zentaris (AEZS) United States $0.010B 0.00
VIVUS (VVUS) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00